MXPA03006648A - Anti-thrombotic compounds, production and use thereof as medicaments. - Google Patents

Anti-thrombotic compounds, production and use thereof as medicaments.

Info

Publication number
MXPA03006648A
MXPA03006648A MXPA03006648A MXPA03006648A MXPA03006648A MX PA03006648 A MXPA03006648 A MX PA03006648A MX PA03006648 A MXPA03006648 A MX PA03006648A MX PA03006648 A MXPA03006648 A MX PA03006648A MX PA03006648 A MXPA03006648 A MX PA03006648A
Authority
MX
Mexico
Prior art keywords
medicaments
production
thrombotic compounds
thrombotic
compounds
Prior art date
Application number
MXPA03006648A
Other languages
Spanish (es)
Inventor
Priepke Henning
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10104597A external-priority patent/DE10104597A1/en
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MXPA03006648A publication Critical patent/MXPA03006648A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MXPA03006648A 2001-02-02 2002-01-26 Anti-thrombotic compounds, production and use thereof as medicaments. MXPA03006648A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10104597A DE10104597A1 (en) 2001-02-02 2001-02-02 New (hetero)aryl-substituted amide or amine derivatives, are thrombin and factor Xa inhibitors useful as antithrombotic agents, e.g. for treating deep vein thrombosis or preventing reocclusion after angioplasty
DE10135435 2001-07-26
PCT/EP2002/000823 WO2002062778A2 (en) 2001-02-02 2002-01-26 Anti-thrombotic compounds, production and use thereof as medicaments

Publications (1)

Publication Number Publication Date
MXPA03006648A true MXPA03006648A (en) 2003-10-15

Family

ID=26008392

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03006648A MXPA03006648A (en) 2001-02-02 2002-01-26 Anti-thrombotic compounds, production and use thereof as medicaments.

Country Status (5)

Country Link
EP (1) EP1390357A2 (en)
JP (1) JP2004522759A (en)
CA (1) CA2435492A1 (en)
MX (1) MXPA03006648A (en)
WO (1) WO2002062778A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030181488A1 (en) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
DE10234058A1 (en) * 2002-07-26 2004-02-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg New substituted benzoic acid amides, their production and their use as medicines
WO2004014844A2 (en) * 2002-08-09 2004-02-19 Transtech Pharma, Inc. Aryl and heteroaryl compounds and methods to modulate coagulation
US7247654B2 (en) 2003-06-04 2007-07-24 Bristol-Myers Squibb Company 3,4-disubstituted benzamidines and benzylamines, and analogues thereof, useful as serine protease inhibitors
US7570259B2 (en) 2004-06-01 2009-08-04 Intel Corporation System to manage display power consumption
AU2005281934A1 (en) * 2004-09-06 2006-03-16 F. Hoffmann-La Roche Ag 4-aminomethyl benzamidine derivatives and their use as factor VIIA inhibitors
DE602005009252D1 (en) 2004-12-08 2008-10-02 Bristol Myers Squibb Co Heterocyclic Compounds as Inhibitors of Factor VIIA
AU2007238755B2 (en) 2006-04-12 2012-07-12 Merck Sharp & Dohme Llc Pyridyl amide T-type calcium channel antagonists
RU2010120671A (en) 2007-10-24 2011-11-27 Мерк Шарп Энд Домэ Корп. (Us) HETEROCYCLIC PHENYLAMIDE ANTAGONISTS OF T-TYPE CALCIUM CHANNELS
JP6616790B2 (en) 2014-06-27 2019-12-04 ノグラ ファーマ リミテッド Aryl receptor modulators and methods of making and using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD142804A3 (en) * 1977-11-07 1980-07-16 Wagner Guenter PROCESS FOR PREPARING NA-ALKYL-BZW.NA-ARYL-SULFONYLATED OMEGA-AMIDINOPHENYL-ALPHA-AMINOALKYLCARBONESAFEAMIDES
EP0654465A1 (en) * 1993-11-15 1995-05-24 Ciba-Geigy Ag Polyaminopolyamides
US5741819A (en) * 1995-06-07 1998-04-21 3-Dimensional Pharmaceuticals, Inc. Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitors
WO2000056707A1 (en) * 1999-03-24 2000-09-28 Sepracor, Inc. Diaryl thioethers, compositions and uses thereof
CA2380986C (en) * 1999-08-07 2009-10-20 Boehringer Ingelheim Pharma Kg Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
DE10033337A1 (en) * 2000-07-08 2002-01-17 Boehringer Ingelheim Pharma Biphenylcarboxamides, their preparation and their use as medicaments

Also Published As

Publication number Publication date
JP2004522759A (en) 2004-07-29
CA2435492A1 (en) 2002-08-15
WO2002062778A3 (en) 2003-12-11
WO2002062778A2 (en) 2002-08-15
EP1390357A2 (en) 2004-02-25

Similar Documents

Publication Publication Date Title
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
AU2003293757A1 (en) Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments
HUP0401293A3 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
DE60223699D1 (en) Diarylsulfidderivat, dessen additionssalz und immunsuppressivum
AU2002337047A1 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
HK1142886A1 (en) Bicyclic compound, production and use thereof
MXPA03007349A (en) Xanthine derivative, production and use thereof as a medicament.
IL159120A0 (en) Cdk inhibiting pyrimidines, production thereof and their use as medicaments
AU2002312933A1 (en) CDK inhibiting pyrimidines, production thereof and their use as medicaments
ZA200305498B (en) Xanthine derivative, production and use thereof as a medicament.
PL366794A1 (en) Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments
ZA200500877B (en) Antimicrobial aza-bicyclic derivatives, their compositions and uses.
HUP0401648A3 (en) 6-hydroxy isoflavon compounds, their derivatives and medicaments involving the same
IL175245A0 (en) Thiozolidinones, production and use thereof as medicaments
ZA200501431B (en) 5-Aryltetrazole compounds, compositions thereof, and uses therefor.
HK1081965A1 (en) Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
IL164442A0 (en) Benzoxazinone-derived compounds, their preparationand use as medicaments
MXPA03008630A (en) Arylisoxazoline derivatives, method for production and use thereof as pesticides.
IL162316A0 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t
HUP0400155A3 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
MXPA03009002A (en) 5-halogen-6-phenyl-7-fluoralkylamino-triazolopyrimidines as fungicides.
MXPA03006648A (en) Anti-thrombotic compounds, production and use thereof as medicaments.
MXPA03008186A (en) Anti-thrombotic carboxylic acid amides, the production thereof and use of the same as medicaments.
ZA200400092B (en) Product manufacturing line.
HUP0300222A3 (en) Novel lhrh-antagonists, production and use thereof as medicament